Finance

Lists
Why is IMMX down ၉.၆၆%?
Dive Deeper
IMMX:NASDAQ
Immix Biopharma Inc
၇.၂၀ US$
-၉.၆၆%
(-၀.၇၇) 1D
၇.၁၃ US$
-၀.၉၇% (-၀.၀၇၀)
After hours
Closed: နို ၅, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMMX...
Open
၇.၈၆ US$
High
၇.၉၅ US$
Low
၇.၁၂ US$
Mkt. cap
၅၉.၆၉ ကုဋေ
Avg. vol.
၁.၅၃ သန်း
Volume
၁.၄၁ သန်း
52-wk high
၁၅.၁၀ US$
52-wk low
၂.၈၅ US$
EPS
-၀.၈၇ US$
Beta
၀.၂၉
Shares outstanding
၈.၂၉ ကုဋေ
No. of employees
၂၁
Open
၇.၈၆ US$
High
၇.၉၅ US$
Low
၇.၁၂ US$
Mkt. cap
၅၉.၆၉ ကုဋေ
Avg. vol.
၁.၅၃ သန်း
Volume
၁.၄၁ သန်း
52-wk high
၁၅.၁၀ US$
52-wk low
၂.၈၅ US$
EPS
-၀.၈၇ US$
Beta
၀.၂၉
Shares outstanding
၈.၂၉ ကုဋေ
No. of employees
၂၁
News stories
From web sources and news partners
ChartMill
ChartMill
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 Top Movers: Gainers and Losers in Nov. 5, 2026 Session
Traders Union
Traders Union
·
ပြီးခဲ့သည့် ၄၈ မိနစ်
Michael Saylor: S&P 500 and Nasdaq see sharp declines, Bitcoin drops about 5 percent
About Immix Biopharma Inc
CEO-
Employees၂၁
Founded၂၀၁၂
Headquartersလော့စ်အိန်ဂျယ်လိစ်မြို့, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to IMMX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IMMX in the last 3 months.
Highest
Current ၇.၂၀ US$
၃၀.၀၀ US$ (+၃၁၆.၆၇%)
Average
၂၅.၃၃ US$ (+၂၅၁.၈၁%)
Lowest
၂၀.၀၀ US$ (+၁၇၇.၇၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
၂၃.၀၀ US$
+၂၁၉.၄%
10/29/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
၂၀.၀၀ US$
+၁၇၇.၈%
10/20/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
၂၄.၀၀ US$
+၂၃၃.၃%
10/03/2026
Gil Blum
Needham
Buy
Reiterated
၃၀.၀၀ US$
+၃၁၆.၇%
09/29/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
၃၀.၀၀ US$
+၃၁၆.၇%
09/29/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၂၅.၀၀ US$
+၂၄၇.၂%
08/10/2026
Reni Benjamin
Citizens JMP
Buy
Initiated
၂၃.၀၀ US$
+၂၁၉.၄%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၄.၅၈ သန်း
၅.၇၃ သန်း
၅.၉၈ သန်း
၅.၃၃ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၀၈ သန်း
၅.၁၇ သန်း
၄.၈၂ သန်း
၇.၁၂ သန်း
Operating expense
၇.၆၆ သန်း
၁.၀၉ ကုဋေ
၁.၀၈ ကုဋေ
၁.၂၅ ကုဋေ
Total operating expenses
၇.၆၆ သန်း
၁.၀၉ ကုဋေ
၁.၀၈ ကုဋေ
၁.၂၅ ကုဋေ
Operating income
-၇.၆၆ သန်း
-၁.၀၉ ကုဋေ
-၁.၀၈ ကုဋေ
-၁.၂၅ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၇.၅၈ သန်း
-၁.၀၇ ကုဋေ
-၁.၀၁ ကုဋေ
-၁.၁၅ ကုဋေ
EBT excluding unusual items
-၇.၅၈ သန်း
-၁.၀၇ ကုဋေ
-၁.၀၁ ကုဋေ
-၁.၁၅ ကုဋေ
Income tax expense
၇.၇၂ ထောင်
၁.၁၃ သောင်း
-
၁.၄၃ သောင်း
Effective tax rate
-၀.၁၀%
-၀.၁၁%
-
-၀.၁၂%
Other operating expenses
-
-
-
-
Net income
-၇.၅၉ သန်း
-၁.၀၇ ကုဋေ
-၁.၀၁ ကုဋေ
-၁.၁၆ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၂၄
-၀.၂၈
-၀.၁၈
-၀.၁၈
Interest and investment income
၈.၄၅ သောင်း
၂.၁၇ သိန်း
၇.၁၇ သိန်း
၉.၁၄ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၈.၄၅ သောင်း
၂.၁၇ သိန်း
၇.၁၇ သိန်း
၉.၁၄ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၇.၅၇ သန်း
-၁.၀၈ ကုဋေ
-၁.၀၇ ကုဋေ
-၁.၂၄ ကုဋေ
Gain or loss from assets sale
-
-
၃.၄၂ သောင်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ